Intravenous Cefuroxime Dosing in Adults
Cefuroxime for injection dosing is 750 mg to 1.5 g every 8 hours for most adult infections, usually for 5 to 10 days. [1] In uncomplicated urinary tract infections, skin and skin-structure infections, disseminated gonococcal infections, and uncomplicated pneumonia, 750 mg every 8 hours is recommended. [1] In severe or complicated infections, 1.5 g every 8 hours is recommended. [1]
Intravenous Cefuroxime Dosing for Severe or Life-Threatening Infections
In life-threatening infections or infections due to less susceptible organisms, 1.5 g every 6 hours may be required. [1] In bacterial meningitis, the dose should not exceed 3 g every 8 hours. [1]
Intravenous Cefuroxime Dosing With Renal Impairment (Adults)
A reduced dose is required for impaired renal function. [1] For adults with creatinine clearance (CrCl):
- CrCl >20 mL/min: 750 mg to 1.5 g every 8 hours. [1]
- CrCl 10 to 20 mL/min: 750 mg every 12 hours. [1]
- CrCl <10 mL/min: 750 mg every 24 hours. [1] Cefuroxime is dialyzable, and an additional dose should be given at the end of hemodialysis. [1]
Intravenous Cefuroxime Dosing in Pediatric Patients (>3 Months of Age)
For pediatric patients above 3 months of age, 50 to 100 mg/kg/day in equally divided doses every 6 to 8 hours is successful for most infections susceptible to cefuroxime. [1] For more severe or serious infections, 100 mg/kg/day is recommended, with a maximum of the adult dosage. [1] In bone and joint infections, 150 mg/kg/day (not to exceed the maximum adult dosage) is recommended in equally divided doses every 8 hours. [1]
Intravenous Cefuroxime Dosing for Pediatric Bacterial Meningitis
In bacterial meningitis, 200 to 240 mg/kg/day intravenously in divided doses every 6 to 8 hours is recommended. [1]
Pediatric Renal Impairment Dosing
In pediatric patients with renal insufficiency, dosing frequency should be modified consistent with adult recommendations. [1]
Key Administration Considerations for Intravenous Use
The IV route may be preferable for bacterial septicemia or other severe or life-threatening infections, or for poor-risk patients. [1] The pharmacy bulk package is intended for intravenous infusion solution preparation. [1]
Ongoing Therapy Duration and Monitoring
Administration should continue for a minimum of 48 to 72 hours after the patient becomes asymptomatic or after evidence of bacterial eradication. [1] A minimum of 10 days of treatment is recommended for infections caused by Streptococcus pyogenes. [1] Evaluation of renal status during therapy is recommended, especially in seriously ill patients receiving maximum doses. [1]